share_log

HC Wainwright & Co. Reiterates Buy on Eledon Pharma, Maintains $13 Price Target

Benzinga ·  Nov 13, 2023 20:47

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $13 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment